Order results by:
| Issue | Title | |
| Vol 6, No 4 (2014) | Nondrug therapy in the combination rehabilitation of patients with Parkinson’s disease | Abstract similar documents |
| V. L. Golubev, A. B. Kamakinova | ||
| "... on the use of current drugs and different variants of nondrug therapy. Within the current concept of medical ..." | ||
| Vol 5, No 3 (2013) | Lower back pain: Therapy in the context of evidence-based medicine and new possibilities | Abstract similar documents |
| Aleksei Vladimirovich Sergeev | ||
| "... considers main approaches to drug and nondrug therapies for nonspecific acute LBP in the context of current ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Cognitive reserve and cognitive impairments: drug and nondrug treatments | Abstract similar documents |
| E.I. Dainikova, N.V. Pizova | ||
| "... and Parkinson's disease, are covered. The issues of correcting CIs in cerebrovascular and neurodegenerative ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Non-drug therapies for cognitive impairment | Abstract similar documents |
| I. S. Preobrazhenskaya, D. Fantalis, S. A. Abdyshova, A. A. Kindarova | ||
| "... -drug therapies in patients with Alzheimer’s disease. ..." | ||
| Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
| A. V. Obukhova | ||
| "... The main goal of therapy for Parkinson's disease (PD) is to correct dopamine deficiency ..." | ||
| Vol 9, No 4 (2017) | Sleep disorders in Parkinson’s disease: approaches to treatment and prevention | Abstract similar documents |
| M. R. Nodel, G. V. Kovrov | ||
| "... Nocturnal sleep disorders are one of the most important non-motor manifestations of Parkinson’s ..." | ||
| Vol 5, No 1 (2013) | Dopamine dysregulation syndrome in Parkinson’s disease | Abstract similar documents |
| A V Nikitina, Natalia Vladimirovna Fedorova | ||
| "... therapy. According to the data available in the literature, DDS develops in 3-4% of the Parkinson’s ..." | ||
| Vol 2, No 4 (2010) | Depression in Parkinson's disease | Abstract similar documents |
| M. R. Nodel' | ||
| "... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a wide spectrum ..." | ||
| Vol 6, No 1 (2014) | Apathy in Parkinson's disease patients | Abstract similar documents |
| M. R. Nodel | ||
| "... pathy in Parkinson's disease (PD) patients is one of the least studied manifestations of a broad ..." | ||
| Vol 5, No 2 (2013) | Current possibilities of therapy for sleep disorders in Parkinson’s disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... and awakening disorders in patients with Parkinson's disease (PD). It covers the current views of the role ..." | ||
| Vol 16, No 3 (2024) | Treatment of the early stages of Parkinson's disease. Differences in approaches to the choice of therapy in different countries | Abstract similar documents |
| E. V. Bril, N. V. Fedorova, T. K. Kulua, O. S. Zimnyakova | ||
| "... The review addresses an approach to the treatment of early stages of Parkinson's disease (PD ..." | ||
| Vol 12, No 4 (2020) | Diagnosis and treatment of migraine: Russian experts' recommendations | Abstract similar documents |
| E. G. Filatova, V. V. Osipova, G. R. Tabeeva, V. A. Parfenov, E. V. Ekusheva, Yu. E. Azimova, N. V. Latysheva, M. V. Naprienko, K. V. Skorobogatykh, A. V. Sergeev, V. A. Golovacheva, E. R. Lebedeva, A. R. Artyomenko, O. V. Kurushina, M. I. Koreshkina, A. V. Amelin, L. R. Akhmadeeva, A. R. Rachin, E. D. Isagulyan, Al. B. Danilov, A. B. Gekht | ||
| "... and the amount of analgesics taken. It includes three main approaches: behavioral therapy, seizure relief therapy ..." | ||
| Vol 12, No 5 (2020) | On the heterogeneity of depression in Parkinson’s disease | Abstract similar documents |
| M. R. Nodel, N. N. Yakhno | ||
| "... Depression in Parkinson’s disease (PD) is one of the leading manifestations of the disease, which ..." | ||
| Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
| Oleg Semenovich Levin, V K Datiyeva | ||
| "... receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries ..." | ||
| Vol 4, No 1 (2012) | Sleep and awakening disorders in Parkinson’s disease: comprehensive approach to therapy | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... and awakening disorders in patients with Parkinson’s disease (PD). It covers the current views of the role ..." | ||
| Vol 16, No 2 (2024) | Efficacy of antiparkinsonian therapy in tremor correction according to tremorography | Abstract similar documents |
| V. A. Bogacheva, D. V. Zakharov, V. A. Mikhailov | ||
| "... the frequency-amplitude characteristics in the correction of tremulous hyperkinesis in Parkinson's disease (PD ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Drug therapy and cognitive stimulation in patients with poststroke cognitive impairments | Abstract similar documents |
| D.R. Khasanova, Yu.V. Zhitkova, L.M. Yu.V. | ||
| "... ) actovegin infusions; 3) cerebrolysin infusions; 4) drug therapy in combination with non-drug cognitive ..." | ||
| Vol 15, No 6 (2023) | Effect of dopaminergic therapy on lacrimation in Parkinson's disease | Abstract similar documents |
| A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov, A. V. Kuchuk | ||
| "... The prevalence of dry eye syndrome (DES) in Parkinson's disease (PD) reaches 87% and leads ..." | ||
| Vol 16, No 3 (2024) | Rhythmic transcranial magnetic stimulation in the treatment of cervical dystonia and comorbid mental disorders | Abstract similar documents |
| A. A. Ragimova, D. S. Petelin, A. N. Galyautdinova, V. A. Tolmacheva, B. A. Volel | ||
| Vol 8, No 4 (2016) | HYPERSOMNIA AND CIRCADIAN DISTURBANCES IN PARKINSON’S DISEASE | Abstract similar documents |
| M. R. Nodel | ||
| "... studied symptoms of Parkinson’s disease (PD). It manifests as constant excessive sleepiness during the day ..." | ||
| Vol 4, No 1 (2012) | Sustained-release pramipexole in the treatment of Parkinson’s disease | Abstract similar documents |
| Natalia Vladimirovna Fedorova | ||
| "... for dopaminergic deficiency in Parkinson’s disease (PD). Since 1996, pramipexole has been used to treat early ..." | ||
| Vol 15, No 3 (2023) | Parkinson’s disease. Focus on early stages | Abstract similar documents |
| E. A. Katunina, Z. A. Zalyalova, D. V. Pokhabov, M. Z. Ivanova, A. M. Semenova | ||
| "... in the early stages of Parkinson’s disease (PD) and considers the hypothesis of the presence of body-first ..." | ||
| Vol 17, No 3 (2025) | Parkinson's disease and migraine | Abstract similar documents |
| Z. A. Zalyalova, E. A. Katunina, D. V. Pokhabov | ||
| "... Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Migraine ..." | ||
| Vol 3, No 1 (2011) | Sleep disorders in Parkinson's disease | Abstract similar documents |
| M. R. Nodel | ||
| "... of Parkinson's disease (PD). Objective: to specify the clinical features of sleep disorders in patients ..." | ||
| Vol 5, No 3 (2013) | The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... patch in Parkinson's disease (PD) and discusses the results of clinical trials of Rotigotine in early ..." | ||
| Vol 6, No 2 (2014) | Experience with non-drug therapies (psychotherapy, phytotherapy, reflexotherapy) for neurasthenia | Abstract similar documents |
| S.A Bozhko, N.A. Tyuvina | ||
| "... the therapy, all the patients showed a stable reduction in emotional lability and a decrease in the magnitude ..." | ||
| Vol 11, No 2 (2019) | Pathogenesis, clinical features, and treatments of depression in Parkinson's disease | Abstract similar documents |
| I. V. Milyukhina | ||
| "... Depression is the most common non-motor manifestation of Parkinson's disease (PD), which ..." | ||
| Vol 3, No 4 (2011) | Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole | Abstract similar documents |
| M. R. Nodel | ||
| "... Fatigability is a common nonmotor symptom in Parkinson's disease (PD), which worsens quality ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Typical clinical practice of treating patients with chronic migraine | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva, A. R. Tarshilova, V. V. Osipova | ||
| "... admitted to CND had previously received cognitive-behavioral therapy and treatment ..." | ||
| Vol 15, No 1 (2023) | Efficacy of a combination of non-drug therapies in patients with non-dementia vascular cognitive impairment | Abstract similar documents |
| M. S. Novikova, V. V. Zakharov, N. V. Vakhnina | ||
| "... after 12 months of follow-up. Conclusion. Multimodal non-drug therapy in patients with moderate ..." | ||
| Vol 1, No 2 (2009) | NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE | Abstract similar documents |
| M. R. Nodel', N. N. Yakhno | ||
| "... Parkinson's disease (PD) is a multisystemic neurodegenerative disease involving different mediator ..." | ||
| Vol 10, No 4 (2018) | Cognitive and motor training for patients with moderate cognitive impairment and mild dementia | Abstract similar documents |
| A. A. Naumenko, I. S. Preobrazhenskaya | ||
| "... method to basic therapy in patients with Alzheimer's disease (AD) and vascular cognitive impairment (VCI ..." | ||
| Vol 4, No 2 (2012) | Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease | Abstract similar documents |
| S N Illarioshkin | ||
| "... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..." | ||
| Vol 4, No 3 (2012) | Clinical experience with requip modutab | Abstract similar documents |
| Denis Valeryevich Zakharov, V A Mikhailov | ||
| "... of therapy for extensive-stage Parkinson’s disease (PD) and to correct motor fluctuations and drug-induced ..." | ||
| Vol 11, No 4 (2019) | Facet joint osteoarthritis as a cause of chronic low back pain | Abstract similar documents |
| D. O. Rozhkov, O. E. Zinovyeva, A. N. Barinov, A. M. Nosovsky | ||
| "... ; the remaining 93 (77%) patients received combination therapy with anesthetics injected into the region of the FJ ..." | ||
| Vol 9, No 1 (2017) | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease | Abstract similar documents |
| G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov | ||
| "... with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... Depression is one of the most common non-motor manifestations of Parkinson's disease (PD), which ..." | ||
| Vol 8, No 4 (2016) | ALZHEIMER’S DISEASE: DIAGNOSIS AND TREATMENT | Abstract similar documents |
| A. A. Naumenko, D. O. Gromova, N. V. Trofimova, I. S. Preobrazhenskaya | ||
| "... ; methods for pathogenetic therapy are being actively developed. When treating AD, one should adhere ..." | ||
| Vol 12, No 1 (2020) | Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. G. Govorova, N. A. Shnaider, M. R. Sapronova | ||
| "... Levodopa remains the gold standard of treating Parkinson's disease (PD). However, the inevitable ..." | ||
| Vol 14, No 4 (2022) | Piribedil in the treatment of mental and cognitive impairments in Parkinson's disease | Abstract similar documents |
| E. V. Yakovenko, F. A. Abbasov | ||
| "... Mental and cognitive impairments are common non-motor symptoms of Parkinson's disease (PD), which ..." | ||
| Vol 7, No 3 (2015) | Experience in using levodopa-benserazide | Abstract similar documents |
| Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova | ||
| "... Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper ..." | ||
| Vol 16, No 6 (2024) | Comorbidity of sialorrhea and depression in patients with Parkinson's disease, their mutual influence on the severity of symptoms and the success of therapy | Abstract similar documents |
| D. V. Zakharov, D. D. Kokareva | ||
| "... of Parkinson's disease at all stages of the disease. They impair the patient's quality of life and ability ..." | ||
| Vol 2, No 2 (2010) | Cervicogenic headache: pathophysiology, clinical picture, approaches to therapy | Abstract similar documents |
| G. R. Tabeeva, A. V. Sergeev | ||
| "... the mechanisms of CH, the clinical diagnosis and effective therapy of this condition present considerable ..." | ||
| Vol 14, No 6 (2022) | A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study | Abstract similar documents |
| Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova | ||
| "... Amantadine has begun to be used as a possible alternative in COVID-19 therapy to mitigate its ..." | ||
| Vol 13, No 6 (2021) | Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease | Abstract similar documents |
| E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova | ||
| "... . Patients and methods. The study included 75 patients with Parkinson's disease (PD): 49 (65.3%) women and 26 ..." | ||
| Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
| N. V. Trofimova, I. S. Preobrazhenskaya | ||
| "... with clinical presentations of mental confusion. Cyticolin therapy is used to reduce the risk of side effects ..." | ||
| Vol 12, No 6 (2020) | Cerebral glucose metabolism and cognitive impairment in tremor-dominant and akinetic-rigid subtypes of Parkinson’s disease | Abstract similar documents |
| I. V. Miliukhina, Yu. G. Khomenko, E. V. Gracheva, G. V. Kataeva, E. A. Gromova | ||
| "... Parkinson’s disease (PD) is a disease characterized by marked phenotypic heterogeneity ..." | ||
| Vol 3, No 3 (2011) | Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®) | Abstract similar documents |
| M. R. Nodel | ||
| "... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a broad spectrum ..." | ||
| Vol 10, No 4 (2018) | Approaches to therapy for depressions in neurology: prospects for the use of agomelatine | Abstract similar documents |
| D. V. Romanov, B. A. Volel, D. S. Petelin | ||
| "... of patients with post-stroke depression, Parkinson’s disease, Alzheimer’s disease, Pick’s disease, Huntington ..." | ||
| Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
| Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
| "... Motor and non-motor symptoms are identified in the clinical picture of Parkinson's disease (PD ..." | ||
| Vol 11, No 3 (2019) | The use of vortioxetine for the correction of depression in Parkinson's disease: an example of clinical cases | Abstract similar documents |
| I. V. Miliukhina | ||
| "... The prevalence of depression in Parkinson's disease (PD) amounts to as much as 90%. The paper ..." | ||
| Vol 10, No 4 (2018) | Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease | Abstract similar documents |
| M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno | ||
| "... Daytime sleepiness is one of the clinically significant non-motor manifestations of Parkinson ..." | ||
| Vol 13, No 5 (2021) | Modern approaches to the treatment of fibromyalgia | Abstract similar documents |
| T. I. Nasonova, A. Kh. Mukhametzyanova, G. R. Tabeyeva, P. A. Chernousov | ||
| "... of cognitive-behavioral and mindfulness therapy, kinesiotherapy, and biofeedback has been shown ..." | ||
| Vol 12, No 2 (2020) | Atypical depression: selection criteria, systematics, approaches to therapy | Abstract PDF (Eng) similar documents |
| N. A. Tyuvina, M. S. Verbitskaya, A. E. Stolyarova | ||
| "... activity therapy) treatments. ..." | ||
| Vol 14, No 6 (2022) | Mild cognitive impairment treatment issues | Abstract similar documents |
| L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... therapies for MCI. Multiple pharmacological effects of citicoline on cognitive functions of patient ..." | ||
| Vol 7, No 2 (2015) | Treatment for chronic daily headache by using auxiliary and alternative methods | Abstract similar documents |
| V. A. Golovacheva, V. A. Parfenov, V. V. Zakharov | ||
| "... about his/her disease. A combination of drug and non-drug therapies is the mainstay of the current ..." | ||
| Vol 1, No 1 (2009) | ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE | Abstract similar documents |
| I. S. Yavelov | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | Effectiveness of Epilepsy Therapy in Adults after Correction Performed by an Epileptologist | Abstract similar documents |
| S. R. Nurmukhametova, R. V. Magzhanov | ||
| "... on the results of examination and therapy correction performed by an epileptologist. Patients and Methods ..." | ||
| Vol 1, No 1 (2009) | MEDICAL INFORMATION IN THE STRUCTURE OF COGNITIVE THERAPY FOR PANIC DISORDER | Abstract similar documents |
| A. M. Burno | ||
| "... The paper describes the procedure of cognitive therapy for panic disorder, which is based ..." | ||
| Vol 16, No 3 (2024) | Psychotic disorders in Parkinson's disease: phenomenology, pathogenesis, therapeutic approaches (modern view on the problem) | Abstract similar documents |
| Kh. I. Alizade, A. A. Ragimova, E. Yu. Fedotova, S. N. Illarioshkin | ||
| "... Psychotic disorders in Parkinson's disease (PD) are common non-motor manifestations that have ..." | ||
| Vol 7, No 3 (2015) | Specific features of reperfusion therapy for vertebrobasilar ischemic stroke | Abstract similar documents |
| K. V. Anisimov, A. P. Tolmachev, Nikolai Anatolyevich Shamalov | ||
| "... and disability; reperfusion therapy in patients with a lesion focus in the VBS is safe and effective beyond the 4 ..." | ||
| Vol 6, No 3 (2014) | Factors influencing the efficiency and safety of systemic thrombolysis in patients with ischemic stroke | Abstract similar documents |
| N. A. Shamalov, K. V. Anisimov, M. A. Kustova, A. P. Tolmachev | ||
| "... and safe therapy option for ischemic stroke (IS) in the first 4.5 hours after onset of the disease ..." | ||
| Vol 6, No 3 (2014) | Analysis of reasons for low adherence to antiepileptic therapy in patients with symptomatic epilepsy | Abstract similar documents |
| M. A. Vagina, L. I. Volkova | ||
| "... of social stigmatization in epileptic patients. Patients with severe epilepsy on multiple drug therapy were ..." | ||
| Vol 4, No 1 (2012) | Fibromyalgia: development of symptoms and principles of therapy | Abstract similar documents |
| Gyuzel Rafkatovna Tabeyeva | ||
| Vol 5, No 4 (2013) | Platelet antiaggregants in the treatment and prevention of ischemic stroke | Abstract similar documents |
| Andrei Viktorovich Fonyakin | ||
| "... The review of literature gives current views on the role of antiplatelet therapy in the treatment ..." | ||
| Vol 5, No 3 (2013) | Analysis of factors influencing the early efficiency of systemic thrombolytic therapy for ischemic stroke | Abstract similar documents |
| Elena Vladimirovna Prazdnichkova, A M Alasheev, O A Shalagina, L I Volkova | ||
| "... he paper shows the urgency of enhancing the efficiency of systemic thrombolytic therapy (TLT ..." | ||
| Vol 15, No 2 (2023) | The use of antidepressants in neurological practice | Abstract similar documents |
| V. A. Parfenov | ||
| "... 's disease, depression with cognitive impairment, Parkinson's disease, multiple sclerosis, chronic back pain ..." | ||
| Vol 14, No 3 (2022) | Combined therapy for Alzheimer's disease | Abstract similar documents |
| V. V. Zakharov, A. V. Lokshina, N. V. Vakhnina | ||
| "... to the problem of combined therapy of dementia in AD with donepezil and memantine are considered. The fixed ..." | ||
| Vol 11, No 3 (2019) | Advances in neurometabolic therapy | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina | ||
| "... symmetric diabetic polyneuropathy and that it is used as additional therapy for primary degenerative ..." | ||
| Vol 3, No 4 (2011) | Current therapy for cognitive impairments | Abstract similar documents |
| N. V. Vakhnina | ||
| "... , i.e. basic therapy for the most common forms of dementia (Alzheimer's disease, Lewy body dementia ..." | ||
| 1 - 70 of 857 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
